Vision Restoration

.Clinical

Opus Genetics Advances OPGx-BEST1 Toward Phase 3

RESEARCH TRIANGLE PARK, N.C. — September 9, 2026 Opus Genetics, Inc. announced positive 3- and 6-month data from the...

By cGxPwire Editor
September 10, 2026

Bio-Pharma

Kiora Pharmaceuticals Advances Key Clinical Programs

ENCINITAS, Calif., August 7, 2026 Kiora Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress across its...

By cGxPwire Editor
August 8, 2026

Bio-Pharma

Opus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial

RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2026 Opus Genetics, Inc. has completed patient enrollment in its registrational Phase 3...

By cGxPwire Editor
August 4, 2026

.Clinical

Opus Genetics Secures FDA Alignment for Phase 3 Trial

RESEARCH TRIANGLE PARK, N.C., July 6, 2026 Opus Genetics announced that the U.S. Food and Drug Administration (FDA) has...

By cGxPwire Editor
July 7, 2026

.Clinical

Nanoscope Therapeutics Highlights MCO-010 Vision Data at ASGCT 2026

DALLAS, May 11, 2026 Nanoscope Therapeutics announced multiple scientific presentations at the American Society of Gene and Cell Therapy...

By cGxPwire Editor
May 12, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

Beacon Therapeutics Reports Positive XLRP Gene Therapy Data

LONDON and CAMBRIDGE, Mass., May 7, 2026 Beacon Therapeutics announced encouraging 12-month safety and efficacy results from its ongoing...

By cGxPwire Editor
May 9, 2026

.VC

Kiora Raises $24M to Advance Retinal Therapies

ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...